Clinical Trials
16 trialsNCT07620717 2026-06-02
PROCAN-B+
University of Sunderland
Phase NA Not yet recruiting
NCT07615101 2026-06-01
Investigating the Safety and Diagnostic Performance of 68Ga-NYM032 Injection PET/CT in Men With Newly Diagnosed Prostate Cancer.
Norroy Bioscience Co., LTD
Phase 3 Not yet recruiting
NCT07254650 2026-05-28
CALMS-1
University of Texas Southwestern Medical Center
Phase NA Not yet recruiting
NCT07596732 2026-05-19
SUNRISE
AdventHealth Translational Research Institute
Phase NA Not yet recruiting
NCT07593833 2026-05-18
Prospective Sample Collection Study for a Blood-Based cfDNA Methylation Assay for Ovarian Cancer Detection
Tongji Hospital
Not yet recruiting
NCT07582003 2026-05-12
A Phase I Trial of S-Adenosylmethionine (SAMe) for Chemoprevention of Colorectal Adenomas
Cedars-Sinai Medical Center
Phase 1 Not yet recruiting
NCT07578324 2026-05-11
TENS 2
Medical University of Gdansk
Phase NA Not yet recruiting
NCT07430527 2026-05-08
Secondary Care Colorectal Cancer Pathway Review
University of Edinburgh
Not yet recruiting
NCT07574255 2026-05-07
3D-US Construct on Volumetric Assessment of Lung Disease & Clinical Application
National Taiwan University Hospital
Not yet recruiting
NCT07567027 2026-05-05
Improving Cryoablation Efficacy With BARRigel Rectal Spacing (ICE-BARR)
NYU Langone Health
Phase NA Not yet recruiting
NCT07223385 2026-05-04
High Cardiovascular Risk Intervention With Cardio-Oncology Consultation for Prostate Cancer Following Androgen Receptor Pathway Inhibitor (ARPI) Therapy (Heart-Safe)
Cedars-Sinai Medical Center
Phase 2 Not yet recruiting
NCT07549451 2026-04-24
Phase 2 Study Of Imetelstat for Patient With Myelodysplastic/Myeloproliferative Neoplasms
M.D. Anderson Cancer Center
Phase 2 Not yet recruiting
NCT07539701 2026-04-20
CELSIO
Institut universitaire de cardiologie et de pneumologie de Québec, University Laval
Phase NA Not yet recruiting
NCT07529769 2026-04-14
AID-OraL
Assistance Publique - Hôpitaux de Paris
Not yet recruiting
NCT07506889 2026-04-08
EXHALE-CO2
Linkoeping University
Not yet recruiting
NCT07502027 2026-03-30
A Clinical Study of Iparomlimab and Tuvonralimab Combined With SOX Following Heterogeneous Radiotherapy as First-line Treatment for Unresectable Locally Advanced or Metastatic HER2-negative Gastric or Gastroesophageal Junction Adenocarcinoma
Huazhong University of Science and Technology
Phase 4 Not yet recruiting